AzTrials
AzTrials

Gestational Weight GainNCT04025892

Pregnancy Tracking Pilot

A study testing Daily weighing in people with Gestational Weight Gain, run by Duke University at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This pilot study will examine perceptions about daily weighing for pregnant women with overweight or obesity by testing the feasibility, acceptability, and preliminary efficacy of daily weighing for reducing excess gestational weight gain (GWG) within the context of a low intensity, digital-health based intervention… Read more about this study

Who is it for?
Ages 18 to 34 years, women onlyHealthy volunteers can take part
Conditions the study is for
Gestational Weight Gain
What is being tested?
Daily weighing
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
Mar 2020to May 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 34 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • women ages 18-34
  • first pregnancy and at 13-20 weeks' gestation
  • low-risk uncomplicated pregnancy
  • overweight or obese at the time they became pregnant
  • willing to receive emails.

Who cannot join

  • Individuals who are not pregnant
  • not willing to receive emails
  • pregnant women expecting more than a single birth,
  • outside the window of 13-20 weeks' gestation
  • high-risk or complicated pregnancy for which participation would be contraindicated
  • advanced maternal age according to obstetric guidelines (i.e., age 35 or older)
Show all 9Show fewer
  • diabetes
  • history of eating disorders
  • pre-pregnancy weight less than 25 kg/m2or greater than 36 kg/m2 (either not overweight or with extreme obesity)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Duke Global Digital Health Science Center

    Durham, North Carolina, 27708

Other trials in United States

About this study

Official title: A Pilot and Feasibility Study of Daily Weight Tracking to Manage Gestational Weight Gain During Pregnancy

This pilot study will examine perceptions about daily weighing for pregnant women with overweight or obesity by testing the feasibility, acceptability, and preliminary efficacy of daily weighing for reducing excess gestational weight gain (GWG) within the context of a low intensity, digital-health based intervention delivered remotely with electronic feedback to participants.

Being tested
Daily weighing
Keywords
pregnancy, digital health, daily weighing
Medical subject headings
Gestational Weight Gain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Daily weighingBehavioural

    Participants will be asked to use the scale to track their body weight daily at home for six weeks. They will receive a weekly email contact with weight change feedback and either a nutrition or physical activity tip for the week. The study procedures represent minimal risks, and participants will be reminded and encouraged to maintain their regular prenatal care contacts with their provider.

Study groups in NCT04025892
Study groupRoleWhat they receive
Tracking groupExperimentalParticipants will be asked to track weight daily for six weeks
Receives: Behavioral: Daily weighing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Frequency of scale use

    The number of times weight is measured on the scale

    Measured: Approximately 6 weeks

Secondary outcomes (2)
  1. Weight change trajectories during scale use

    Average weight change over the study duration

    Measured: Approximately 6 weeks

  2. Knowledge of gestational weight gain guidelines

    Score of response from baseline survey item inquiring about awareness of gestational weight gain where greater score indicates greater knowledge

    Measured: During baseline visit (~ 1 hour)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jul 2019
  2. Study startMar 2020 (estimated)
  3. Primary completionMay 2020 (estimated)
  4. Study completionMay 2020 (estimated)

Why it stopped: Inadequate resources to support study start-up

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04025892
Sponsor's protocol ID
Pro00102563
Status last verified
May 2019
First submitted
17 Jul 2019
Last updated
9 Mar 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Daily weighing in people with Gestational Weight Gain, run by Duke University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 9 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Frequency of scale use (time frame: Approximately 6 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in